[1]
Youssef M, De Sanctis JB, Kanagaratham C, Tao S, Ahmed E, Radzioch D. Efficacy of optimized treatment protocol using LAU-7b Formulation against Ovalbumin (OVA) and House Dust Mite (HDM) - Induced allergic asthma in atopic hyperresponsive A/J mice. Pharm Res 2020; 37(2): 31.
[2]
Martínez G, Mijares MR, De Sanctis JB. Effects of flavonoids and its derivatives on immune cell responses. Recent Pat Inflamm Allergy Drug Discov 2019; 13(2): 84-104.
[3]
Garić D, De Sanctis JB, Dumut DC, et al. Fenretinide favorably affects mucins (MUC5AC/MUC5B) and fatty acid imbalance in a manner mimicking CFTR-induced correction. Biochim Biophys Acta Mol Cell Biol Lipids 2020; 1865(2)158538
[4]
Martinez GP, Mijares MR, Chávez K, et al. Caracasine acid, an ent-3,4-seco-kaurene, promotes apoptosis and cell differentiation through NFkB signal pathway inhibition in leukemia cells. Eur J Pharmacol 2019; 862172624
[5]
Garić D, De Sanctis JB, Shah J, Dumut DC, Radzioch D. Biochemistry of very-long-chain and long-chain ceramides in cystic fibrosis and other diseases: The importance of side chain. Prog Lipid Res 2019.100998
[6]
Garić D, De Sanctis JB, Shah J, Dumut DC, Radzioch D. Biochemistry of very-long-chain and long-chain ceramides in cystic fibrosis and other diseases: Theimportance of side chain. Prog Lipid Res 2019; 74: 130-44.
[7]
Kanagaratham C, Chiwara V, Ho B, et al. Loss of the zona pellucida-binding protein 2 (Zpbp2) gene in mice impacts airway hypersensitivity and lung lipid metabolism in a sex-dependent fashion. Mamm Genome 2018; 29(3-4): 281-98.
[8]
Subiela JV, Torres SH, De Sanctis JB, Hernández N. Cardiorespiratory responses, nitric oxide production and inflammatory factors in patients with myocardial infarction after rehabilitation. Nitric Oxide 2018; 76: 87-96.
[9]
Romero JA, Acosta ME, Gamboa ND, Mijares MR, De Sanctis JB, Charris JE. Optimization of antimalarial, and anticancer activities of (E)-methyl 2-(7-chloroquinolin-4-ylthio)-3-(4-hydroxyphenyl) acrylate. Bioorg Med Chem 2018; 26(4): 815-23.
[11]
Ozdian T, Holub D, Maceckova Z, et al. Proteomic profiling reveals DNA damage, nucleolar and ribosomal stress are the main responses to oxaliplatin treatment in cancer cells. J Proteomics 2017; 162: 73-85.
[12]
Martínez D, Lema D, Del Carmen Moreno D, Hipólito García A, Valentina Garmendia J, De Sanctis JB. Single nucleotide polymorphisms V4 and T1 of the ADAM33 gene in Venezuelan patients with asthma or chronic obstructive pulmonary disease. Invest Clin 2016; 57(2): 176-86.
[13]
De Sanctis JB. Editorial (Thematic Issue: Immune Modulation). Curr Pharm Des 2016; 22(41): 6207-8. 14
[14]
Veltman M, Stolarczyk M, Radzioch D, et al. Correction of lung inflammation in a F508del CFTR murine cystic fibrosis model by the sphingosine-1-phosphatelyase inhibitor LX2931. Am J Physiol Lung Cell Mol Physiol 2016; 311(5): L1000-14.
[15]
Garcia A, De Sanctis JB. A review of clinical trials of belimumab in the management of systemic lupus erythematosus. Curr Pharm Des 2016; 22(41): 6306-12.
[16]
Santamato A, Panza F, Notarnicola A, et al. Is extracorporeal shockwave therapy combined with isokinetic exercise more effective than extracorporeal shockwave therapy alone for subacromial impingement syndrome? A randomized clinical trial. J Orthop Sports Phys Ther 2016; 46(9): 714-25.
[17]
Benaim G, Pimentel AA, Felibertt P, et al. Sphingosine inhibits the sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA) activity. Biochem Biophys Res Commun 2016; 473(2): 572-7.
[18]
Santamato A, Ranieri M, Cinone N, et al. Postural and balance disorders in patients with Parkinson’s disease: A prospective open-label feasibility study with two months of action observation treatment. Parkinsons Dis 2015; 2015902738
[20]
De Sanctis JB, Garmendia JV. Vaccine therapy update for pregnant, immunocompromised, and chronic diseases patients. Recent Pat Inflamm Allergy Drug Discov 2015; 9(1): 46-53.
[21]
Cerezo D, Peña MJ, Mijares M, Martínez G, Blanca I, De Sanctis JB. Peptide vaccines for cancer therapy. Recent Pat Inflamm Allergy Drug Discov 2015; 9(1): 38-45.
[22]
Garcia A, Fernandez S, Toro F, De Sanctis JB. An overview of hepatitis C vaccines. Recent Pat Inflamm Allergy Drug Discov 2014; 8(2): 85-91.
[23]
Kanagaratham C, Kalivodová A, Najdekr L, et al. Fenretinide prevents inflammation and airway hyperresponsiveness in a mouse model of allergic asthma. Am J Respir Cell Mol Biol 2014; 51(6): 783-92.
[24]
de Sanctis J, Teixeira L, van Duin D, et al. Complex prosthetic joint infections due to carbapenemase- producing Klebsiella pneumoniae: A unique challenge in the era of untreatable infections. Int J Infect Dis 2014; 25: 73-8.
[25]
Lema D, Garcia A, De Sanctis JB. HIV vaccines: A brief overview Scand J Immunol 2014; 80(1): 1-11. 26
[26]
Lachance C, Segura M, Dominguez-Punaro MC, et al. Deregulated balance of omega-6 and omega-3 polyunsaturated fatty acids following infection by the zoonotic pathogen Streptococcus suis. Infect Immun 2014; 82(5): 1778-85.
[27]
Wojewodka G, De Sanctis JB, Bernier J, et al. Candidate markers associated with the probability of future pulmonary exacerbations in cystic fibrosis patients. PLoS One 2014; 9(2)e88567
Related Journals
Current Medicinal Chemistry
Current Pharmaceutical Design
Current Topics in Medicinal Chemistry
Current Respiratory Medicine Reviews
Infectious Disorders - Drug Targets
Endocrine, Metabolic & Immune Disorders - Drug Targets
Anti-Infective Agents
Coronaviruses
Recent Advances in Inflammation & Allergy Drug Discovery
Current Probiotics
Related Books
The NLRP3 Inflammasome: An Attentive Arbiter of Inflammatory Response
Natural Immunomodulators: Promising Therapy for Disease Management
Herbal Immunity Boosters Against COVID-19
Mitochondrial DNA and the Immuno-inflammatory Response: New Frontiers to Control Specific Microbial Diseases
Frontiers in Clinical Drug Research – Anti Allergy Agents
Frontiers in Inflammation
Article Metrics
16
1